Holen Sie sich die Stockscreener-App
1.74
3.33%
-0.06
Handel nachbörslich:
1.74
Schlusskurs vom Vortag:
$1.80
Offen:
$1.76
24-Stunden-Volumen:
1.26M
Relative Volume:
0.21
Marktkapitalisierung:
$127.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.83M
KGV:
-2.2025
EPS:
-0.79
Netto-Cashflow:
$-20.87M
1W Leistung:
-0.57%
1M Leistung:
-19.82%
6M Leistung:
+341.62%
1J Leistung:
+308.07%
1-Tages-Spanne:
$1.665
$1.78
1-Wochen-Bereich:
$1.665
$2.05
52-Wochen-Spanne:
$0.2223
$3.83
Cognition Therapeutics Inc Stock (CGTX) Company Profile
Firmenname
Cognition Therapeutics Inc
Sektor
Branche
Telefon
412-481-2210
Adresse
2403 SIDNEY STREET, PITTSBURGH
Vergleichen Sie CGTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGTX
Cognition Therapeutics Inc
|
1.74 | 158.80M | 0 | -22.83M | -20.87M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cognition Therapeutics Inc Stock (CGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-07-30 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-11-03 | Eingeleitet | B. Riley Securities | Buy |
| 2021-11-03 | Eingeleitet | Oppenheimer | Outperform |
Cognition Therapeutics Inc Aktie (CGTX) Neueste Nachrichten
Visual analytics tools that track Cognition Therapeutics Inc. performanceWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
Evaluating Cognition Therapeutics Inc. with trendline analysisJuly 2025 PostEarnings & Weekly Breakout Opportunity Watchlist - newser.com
Smart tools for monitoring Cognition Therapeutics Inc.’s price actionWeekly Volume Report & Entry Point Confirmation Signals - newser.com
Pattern recognition hints at Cognition Therapeutics Inc. upside2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - newser.com
Will Cognition Therapeutics Inc. stock benefit from upcoming earnings reports2025 Trade Ideas & Scalable Portfolio Growth Ideas - newser.com
Why Cognition Therapeutics Inc. stock appeals to dividend seekers2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Will Cognition Therapeutics Inc. stock benefit from commodity pricesMarket Weekly Review & Daily Volume Surge Signals - newser.com
Can swing trading help recover from Cognition Therapeutics Inc. lossesMarket Activity Summary & Fast Moving Market Watchlists - newser.com
Cognition Therapeutics, Inc.Common Stock (NQ: - FinancialContent
Is it too late to sell Cognition Therapeutics Inc.Quarterly Trade Report & High Win Rate Trade Tips - newser.com
Cognition Therapeutics' (CGTX) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Is Cognition Therapeutics Inc. showing signs of accumulationQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade - sharewise.com
Cognition Therapeutics (NASDAQ:CGTX) Stock Price Up 13.6%Still a Buy? - MarketBeat
Will Cognition Therapeutics Inc. benefit from macro trendsMarket Performance Recap & Risk Controlled Swing Trade Alerts - newser.com
How hedge fund analytics apply to Cognition Therapeutics Inc. stock2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
Has Cognition Therapeutics Inc. found a price floor2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Analyzing drawdowns of Cognition Therapeutics Inc. with statistical toolsWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
Is it time to cut losses on Cognition Therapeutics Inc.2025 Performance Recap & AI Driven Stock Reports - newser.com
Has Cognition Therapeutics Inc. formed a bullish divergenceQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
Does Cognition Therapeutics Inc. stock trade at a discount to peersWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Is Cognition Therapeutics Inc. stock entering bullish territoryJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Can Cognition Therapeutics Inc. stock hit record highs againEarnings Risk Report & Verified Trade Idea Suggestions - newser.com
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Chart based analysis of Cognition Therapeutics Inc. trends2025 Big Picture & Short-Term High Return Strategies - newser.com
What drives Cognition Therapeutics Inc stock priceStock Split Announcements & Budget Friendly Trading Ideas - earlytimes.in
Finanzdaten der Cognition Therapeutics Inc-Aktie (CGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):